NAVA LIMITED

NAVA LIMITED

NAVA LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, with attached certificates from KFin Technologies Limited and National Securities Depository Limited, confirming the details of securities dematerialized/rematerialized during the quarter ended June 30, 2026.

NAVA LIMITED

NAVA LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

NAVA LIMITED

NAVA LIMITED's Board of Directors has approved the amalgamation of its wholly-owned subsidiary, Nava Healthcare Pte. Ltd. (NHPL), with another wholly-owned subsidiary, Nava Global Pte. Ltd. (NGPL), both based in Singapore. This internal reorganization aims to consolidate the Group's investments (excluding commercial agriculture and O&M services) under a single platform, NGPL, to streamline its holding structure. The move is intended to facilitate strategic business restructuring and enable NGPL to pursue future expansion into value-added healthcare services and other growth opportunities in South East Asia. The transaction is subject to regulatory approvals in Singapore and will not alter NAVA Limited's shareholding pattern.

NAVA LIMITED

NAVA LIMITED announced the submission of a disclosure by D.Ashok, a promoter, to the Exchange. This disclosure was made under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This specific regulation typically requires promoters to report details of any encumbered (e.g., pledged) shares they hold in the company. While the announcement content does not include specific financial figures or the number of shares involved, it signals a change in the promoter's shareholding status. Investors should note this disclosure as it relates to promoter activity and potential financial arrangements.